This important study presents a thoughtful design and characterization of chimeric influenza hemagglutinin (HA) head domains combining elements of distinct receptor-binding sites. The results provide ...
Q3 2025 Earnings Call October 30, 2025 8:30 AM EDTCompany ParticipantsJon Cohen - CEO & DirectorIan Harris - Chief ...